(Q42601899)

3 November 2017

Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder (English)

1 reference

3 November 2017

1 reference

Naomi M Simon

1

1 reference

3 November 2017

Alyson K Zalta

2

1 reference

3 November 2017

John J Worthington

3

1 reference

3 November 2017

Elizabeth A Hoge

4

1 reference

3 November 2017

Kelly M Christian

5

1 reference

3 November 2017

Julie C Stevens

6

1 reference

3 November 2017

Mark H Pollack

7

1 reference

3 November 2017

1 January 2006

1 reference

3 November 2017

Depression and Anxiety

1 reference

3 November 2017

23

1 reference

3 November 2017

373-376

1 reference

3 November 2017

6

1 reference

The assessment of anxiety states by rating

3 November 2017

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

21 January 2018

1 reference

Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years

21 January 2018

1 reference

7 January 2021

Sex differences in antidepressant response in recent antidepressant clinical trials

1 reference

7 January 2021

Gender differences in treatment response to sertraline versus imipramine in chronic depression

1 reference

7 January 2021

Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile

1 reference

7 January 2021

Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care.

1 reference

7 January 2021

Gender differences in response to differing antidepressant drug classes: two negative studies

1 reference

7 January 2021

Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study

1 reference

7 January 2021

Are there differences between women's and men's antidepressant responses?

1 reference

7 January 2021

Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder

1 reference

7 January 2021

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions

1 reference

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

7 January 2021

Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20184

1 reference

3 November 2017

1 reference